Results 81 to 90 of about 957 (170)

Avaliação da suscetibilidade a sulbactam-durlobactam e sua combinação com meropenem em isolados do complexo Acinetobacter baumannii provenientes de hemoculturas [PDF]

Introdução: Acinetobacter baumannii (AB) é um importante patógeno nosocomial associado a resistência a múltiplos antibióticos, particularmente carbapenêmicos.
Galvão, Mileny Rosalina
core  

Re: Potent in vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates : author's response

Authors' reply to : Veeraraghavan B, Walia K, Egli A. Re: 'Potent in vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates' by Poirel et al.
Le Terrier, Christophe, Nordmann, Patrice, Poirel, Laurent   +2 more
core   +1 more source

Case report: Successful treatment of OXA-23 neurosurgical infection and meningitis with sulbactam-durlobactam combination therapy

Meningitis caused by species is a rare complication of neurosurgical procedures, although it is associated with high morbidity and mortality. Carbapenem-resistant is particularly difficult to treat, considering the limited selection and tolerability of
Rawlings, Stephen A, Snowdin, Jacob W, Madaio, Michael P, Mercuro, Nicholas J   +3 more
core   +1 more source

Innovative Antibiotic Therapies for Carbapenem-Resistant Gram-Negative Bacterial Infections: Clinical Efficacy, Safety, and Comparative Studies

Microorganisms
This review provides an overview of recent research and advancements in infection prevention and the treatment of drug-resistant bacterial diseases.
Majid Eslami, Amirabbas Safaripour, Seyedeh Zahra Banihashemian, Sahar Nikjoo Niaragh, Mohammad Amin Hemmati, Arefeh Shojaeian, Setayesh Fakhariyan, Atiye Rabbani, Valentyn Oksenych   +8 more
doaj   +1 more source

Sulbactam-durlobactam susceptibility among cefiderocol heteroresistant Acinetobacter

ABSTRACT The ATTACK clinical trial for treatment of carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRAB) isolates determined treatment with sulbactam-durlobactam to be efficacious and safe.
Bikash Bogati, Tugba Ozturk, Sarah W. Satola, David S. Weiss   +3 more
openaire   +1 more source

In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations

Microbiology Spectrum
Carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. represent major threats and have few approved therapeutic options. Non-‍fermenting Gram-negative isolates were collected from hospitalized inpatients from 49 sites in 6 European countries
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D. Perry, Mathias W. Pletz, Stefania Stefani, Ian Morrissey, Christopher Longshaw   +7 more
doaj   +1 more source

Clinical Characteristics and in vitro Activities of Sulbactam-durlobactam and Cefiderocol against Carbapenem-resistant Acinetobacter baumannii Infections in Chinese Children: A Multicenter Study

Objective To systematically characterize the carbapenem-resistant Acinetobacter baumannii (CRAB) infections in children and to identify risk factors associated with 28-day mortality. We evaluated the
Wei Xie, Zhenlong Wang, Chunmei Jing, jingyi Dong, lijun zhang, Gaihuan Zheng, Zhongzheng Xiong, Cai Wang, Yupei Xiang   +8 more
core   +1 more source

Comparative in vitro activity of sulbactam with avibactam or durlobactam against carbapenem-resistant Acinetobacter baumannii

JAC-Antimicrobial Resistance
Abstract Objective To determine the in vitro activity of sulbactam in combination with avibactam or durlobactam with and without meropenem or imipenem against carbapenem-resistant Acinetobacter baumannii clinical isolates.
Ava J Dorazio, Ellen G Kline, Kevin M Squires, Marissa P Griffith, Yohei Doi, Ryan K Shields   +5 more
openaire   +2 more sources

Management of extensively drug-resistant Acinetobacter baumannii bacteremia with cefiderocol and sulbactam-durlobactam: a case report

ASM Case Reports
ABSTRACT Background Extensively drug-resistant (XDR) Acinetobacter baumannii presents an urgent threat to public health due to its significant morbidity and mortality, with ...
E. J. Kim, M. Snyder, K. Macaluso, A. Sonyey, F. Segovia, D. Finkel, D. Cennimo, E. L. Kim   +7 more
openaire   +2 more sources

Successful Treatment with Sulbactam-Durlobactam for Severe Acute Pancreatitis Complicated by Extensively Drug-Resistant Acinetobacter baumannii Infection at Multiple Sites: A Case Report

Infection and Drug Resistance
Zhengmao Ge, Li Li, Longxin Wang, Dengke Liu, Yupeng Liu Department of Critical Care Medicine, The 967 Hospital, Joint Logistics Support Force of PLA, Dalian, 116021, People’s Republic of ChinaCorrespondence: Yupeng Liu, Department of Critical Care ...
Ge Z, Li L, Wang L, Liu D, Liu Y
doaj